U.S. Drug Enforcement Administration
U.S. Government: Agencies/Departments/Divisions | Federal Agencies
Recent News About U.S. Drug Enforcement Administration
-
Distributors object to Gupta's testimony on transition from prescription to street drugs
CHARLESTON – A historian of opioid use and drug policy testified, in a federal trial against three major opioid distributors Wednesday, about three principal opioid epidemics that preceded the ongoing crisis. -
Expert says brains have similar changes with prescription and illicit opioids
CHARLESTON -- While opioid distributors have argued there is no proof of connection between prescription painkiller use and illicit drug use, an expert in the neurobiology of addiction said, during the second day of a landmark federal trial against those distributors, that people who take prescription painkillers and illicit opioids see the same changes in their brain chemistry. -
UPDATE: Landmark federal opioid trial against three drug distributors begins
CHARLESTON – The landmark bellwether trial accusing three major drug distributors of helping fuel the opioid epidemic has begun. -
Amended intermediate court bill passes W.Va. House, heads back to Senate
CHARLESTON – An amended bill that would create a new intermediate appellate court has passed the House of Delegates and now heads back to the state Senate. -
W.Va. AG isn't sure he'll sign off on Purdue Pharma $7 billion bankruptcy plan
CHARLESTON -- West Virginia Attorney General Patrick Morrisey says he wants to do what’s best for the state, and he doesn’t know if that means signing off on Purdue Pharma’s $7 billion bankruptcy plan. -
Biden and DEA could clash on crime, marijuana, open borders
WASHINGTON (Legal Newsline) - President Joe Biden hasn’t identified a candidate for permanent director of the Drug Enforcement Administration and it may be a long time before he does. The agency responsible for prosecuting the nation’s war on drugs is trapped on its own political battlefield as it faces criticism over its failure to contain the spread of deadly opioids while continuing to enforce a federal ban on marijuana that is opposed by White House officials and politicians on the left and right. -
Morrisey joins 20 states against Biden Administration for Keystone Pipeline cancelation
GALVESTON, Texas — West Virginia has joined a lawsuit with 20 other states against President Joe Biden's administration for the cancelation of the Keystone Pipeline. -
Drug companies say Cabell, Huntington should be limited by statute of limitations
BLUEFIELD – A one-year statute of limitations should limit the damages Cabell County and the City of Huntington can seek from three large drug distributors, according to attorneys for the companies. -
More enforcement and control are key to containing opioid crisis
By working more closely with the states, the DEA and its Office of Diversion Control can make its enforcement and diversion control efforts more effective. Like someone once said, we’re “stronger together.” -
DEA again cuts opioid production as companies facing addiction lawsuits put blame on feds
WASHINGTON (Legal Newsline) - The Drug Enforcement Administration has slashed oxycodone production quotas by almost 60% from the peak in 2013, including a 9% cut for this year, demonstrating the government’s firm control over narcotics distribution even as plaintiffs in opioid litigation blame pharmacies and drug distributors for causing addiction and overdose deaths by selling too many pills. -
Health care advocate: 'It is pretty clear' FDA, DEA failed to adequately protect public from opioid crisis
WASHINGTON (Legal Newsline) – The federal Food and Drug Administration and other U.S. drug enforcement arms played significant roles in causing the nation's opioid crisis and their current unwillingness to use modern technology to help combat it is "baffling," the head of a D.C.-based technology and health care advocacy group said. -
DOJ watchdog isn't impressed with the opioid 'Whistleblower'; What will jurors in historic trial think?
CLEVELAND (Legal Newsline) – Is he blowing the whistle or passing the buck? A badge-flashing, gun-toting bulldog, or an ineffective bureaucrat? Is he defined by an appearance on "60 Minutes," or the fact that trial lawyers pay him $500 for 60 minutes of his time? -
'Business decision': Did DEA boss leave opioid distributors hanging?
During the boom of the addiction crisis in America, opioid distributors were told to figure out a system for identifying suspicious orders but what they came up with could never be given a stamp of approval from federal regulators – even if they asked. -
‘Business decision’: Former DEA official works for opioid lawyers but set standards for how many pills were made
Now, Rannazzisi is helping private lawyers pin the blame squarely on manufacturers and distributors of opioids, as well as pharmacies. A post-DEA alliance with trial lawyers has been worth six figures for Rannazzisi, who has been hailed as a whistleblower by those cheering attempts to prosecute the opioid industry for the nation’s addiction crisis. -
Newspapers want federal appeals court to unseal data about opioid crisis
CHARLESTON — Two newspaper companies have filed briefs in a federal appellate court in order to obtain information involving the opioid crisis. -
Justice Department cites ‘substantial financial stake’; Wants role in opioid settlement talks
WASHINGTON (Legal Newsline) – The U.S. government wants a seat at the table as lawyers for hundreds of municipalities and other plaintiffs negotiate a potentially multibillion-dollar settlement of lawsuits over the opioid addiction crisis, citing its “substantial financial stake” in the matter and need to recover its own costs. -
Ohio employers need to prepare for state's new medical marijuana law, attorney says
COLUMBUS, Ohio (Legal Newsline) – Ohio's new law that legalizes medical marijuana in the state may end up conflicting with federal law, depending on a looming decision about whether to change marijuana's drug status, an employment attorney said during a recent interview.